India to develop swine flu vaccine by 2010: Azad
November 24th, 2009 - 8:28 pm ICT by IANS ( Leave a comment )New Delhi, Nov 24 (IANS) India would be able to indigenously develop swine flu vaccine by June next year, Health Minister Ghulam Nabi Azad told parliament Tuesday.
“Three companies are working towards developing indigenous vaccine for the swine flu and it is expected that clinical trials would start in January 2010. If all goes well, indigenous vaccine would be available by June 2010,” Azad said.
In India, three pharmaceutical companies - Serum Institute of India, Bharat Biotech, and Panacea Biotech - are working on developing the vaccine.
Azad said that to cover the interim period, the government is importing pandemic vaccine to vaccinate the high risk group.
“We have procured 40 million capsules and 400,000 bottles of oseltamivir, the drug used to treat swine flu. Restricted sale of the drug is allowed through retail outlets,” said Azad.
- Indigenous H1N1 vaccine launched - Jun 03, 2010
- India-made H1N1 vaccine launched (Lead) - Jun 03, 2010
- Swine flu vaccine yet to hit Delhi markets - Jun 06, 2010
- India will import swine flu vaccine if developed anywhere - Aug 10, 2009
- Over 1,500 swine flu deaths in India, says Azad - May 04, 2010
- India to unveil second swine flu vaccine - Jul 09, 2010
- India developing own influenza vaccine for first time: Azad - Nov 06, 2009
- Pharma firms to conduct H1N1 vaccine human trials in India - Dec 08, 2009
- India to develop swine flu vaccine by early next year: Azad - Dec 26, 2009
- India to produce raw material for swine flu drug, toll touches 220 (Lead) - Sep 17, 2009
- Swine flu affected toll rises to 17 as two more tested positive in Hyderabad - Jun 14, 2009
- Imported swine flu vaccine will reach India in February - Jan 20, 2010
- Swine flu vaccine shortage in Delhi - Jul 14, 2010
- Swine flu vaccine in 'four to seven months', says government - Aug 07, 2009
- Expert worried over safety of swine flu vaccine - Aug 22, 2009
Tags: bharat, clinical trials, flu, ghulam nabi azad, health minister, high risk group, interim period, New Delhi, oseltamivir, panacea, pandemic, parliament, pharmaceutical companies, retail outlets, serum institute of india, swine flu vaccine